Annual CFO
-$21.66 M
+$18.10 M+45.52%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual cash flow from operations is -$21.66 million, with the most recent change of +$18.10 million (+45.52%) on December 31, 2023.
- During the last 3 years, NRXP annual CFO has fallen by -$19.39 million (-856.16%).
- NRXP annual CFO is now -856.16% below its all-time high of -$2.27 million, reached on December 31, 2020.
Performance
NRXP Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$2.31 M
+$256.00 K+9.99%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly cash flow from operations is -$2.31 million, with the most recent change of +$256.00 thousand (+9.99%) on September 30, 2024.
- Over the past year, NRXP quarterly CFO has increased by +$1.36 million (+37.18%).
- NRXP quarterly CFO is now at all-time high.
Performance
NRXP Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$11.73 M
+$2.26 M+16.14%
September 30, 2024
Summary
- As of February 8, 2025, NRXP TTM cash flow from operations is -$11.73 million, with the most recent change of +$2.26 million (+16.14%) on September 30, 2024.
- Over the past year, NRXP TTM CFO has increased by +$7.51 million (+39.02%).
- NRXP TTM CFO is now -289.09% below its all-time high of -$3.02 million, reached on March 31, 2021.
Performance
NRXP TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
NRXP Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +45.5% | +37.2% | +39.0% |
| 3 y3 years | -856.2% | +63.2% | +72.5% |
| 5 y5 years | -856.2% | - | - |
NRXP Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.5% | at high | +84.4% | at high | +75.8% |
| 5 y | 5-year | -856.2% | +45.5% | at high | +84.4% | -289.1% | +75.8% |
| alltime | all time | -856.2% | +45.5% | at high | +84.4% | -289.1% | +75.8% |
NRx Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.31 M(-10.0%) | -$11.73 M(-16.1%) |
| Jun 2024 | - | -$2.56 M(-30.2%) | -$13.99 M(-27.3%) |
| Mar 2024 | - | -$3.67 M(+15.0%) | -$19.24 M(-11.2%) |
| Dec 2023 | -$21.66 M(-45.5%) | -$3.19 M(-30.1%) | -$21.66 M(-19.1%) |
| Sep 2023 | - | -$4.56 M(-41.6%) | -$26.78 M(-6.0%) |
| Jun 2023 | - | -$7.81 M(+28.3%) | -$28.48 M(-19.7%) |
| Mar 2023 | - | -$6.09 M(-26.8%) | -$35.46 M(-10.8%) |
| Dec 2022 | -$39.76 M | -$8.32 M(+32.7%) | -$39.76 M(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$6.27 M(-57.6%) | -$42.72 M(-11.9%) |
| Jun 2022 | - | -$14.79 M(+42.5%) | -$48.47 M(+7.5%) |
| Mar 2022 | - | -$10.38 M(-8.0%) | -$45.07 M(+19.5%) |
| Dec 2021 | -$37.70 M(+1564.6%) | -$11.28 M(-6.1%) | -$37.70 M(+42.7%) |
| Sep 2021 | - | -$12.01 M(+5.4%) | -$26.42 M(+83.4%) |
| Jun 2021 | - | -$11.39 M(+277.9%) | -$14.41 M(+377.9%) |
| Mar 2021 | - | -$3.02 M | -$3.02 M |
| Dec 2020 | -$2.27 M | - | - |
FAQ
- What is NRx Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual CFO year-on-year change?
- What is NRx Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly CFO year-on-year change?
- What is NRx Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals TTM CFO year-on-year change?
What is NRx Pharmaceuticals annual cash flow from operations?
The current annual CFO of NRXP is -$21.66 M
What is the all time high annual CFO for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual cash flow from operations is -$2.27 M
What is NRx Pharmaceuticals annual CFO year-on-year change?
Over the past year, NRXP annual cash flow from operations has changed by +$18.10 M (+45.52%)
What is NRx Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of NRXP is -$2.31 M
What is the all time high quarterly CFO for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly cash flow from operations is -$2.31 M
What is NRx Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, NRXP quarterly cash flow from operations has changed by +$1.36 M (+37.18%)
What is NRx Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of NRXP is -$11.73 M
What is the all time high TTM CFO for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high TTM cash flow from operations is -$3.02 M
What is NRx Pharmaceuticals TTM CFO year-on-year change?
Over the past year, NRXP TTM cash flow from operations has changed by +$7.51 M (+39.02%)